MedTrace Logo

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings

NCT02322762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15992

Last updated 2022-06-09

No results posted yet for this study

Summary

DISCOVER is a Non Interventional Study study to describe the disease management patterns and clinical evolution over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic treatment.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jesus Medina, PhD · AstraZeneca

  • Linong Ji, MD · Peking University People's Hospital, China

  • Bong Soo Cha, Dr. · Severance Hospital, Yonsei University Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-30
Primary Completion
2019-08-21
Completion
2019-08-21

Countries

  • Algeria
  • Argentina
  • Australia
  • Austria
  • Bahrain
  • Brazil
  • China
  • Colombia
  • Costa Rica
  • Czechia
  • Egypt
  • India
  • Indonesia
  • Italy
  • Jordan
  • Kuwait
  • Lebanon
  • Malaysia
  • Mexico
  • Netherlands
  • Oman
  • Panama
  • Poland
  • Russia
  • Saudi Arabia
  • South Africa
  • South Korea
  • Spain
  • Taiwan
  • Tunisia
  • Turkey (Türkiye)
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322762 on ClinicalTrials.gov